Foster Dykema Cabot & Co’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$1K Hold
65
﹤0.01% 314
2023
Q2
$1K Hold
65
﹤0.01% 370
2023
Q1
$1K Buy
+65
New +$1.13K ﹤0.01% 233

Other funds holding EXEL

Foster Dykema Cabot & Co's EXEL Position: Q3 2023 in Review

Foster Dykema Cabot & Co held its Exelixis (EXEL) position steady in Q3 2023 at 65 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #314.

Foster Dykema Cabot & Co first reported a position in EXEL in Q1 2023 and has held it in 3 quarters since. 397 funds tracked by Wall St. Rank hold EXEL as of Q3 2023.

  • Foster Dykema Cabot & Co held 65 shares of Exelixis worth $1K as of Q3 2023.
  • Foster Dykema Cabot & Co left its Exelixis share count unchanged in Q3 2023.
  • Exelixis made up ﹤0.01% of Foster Dykema Cabot & Co's portfolio in Q3 2023, its #314 holding.
  • Foster Dykema Cabot & Co first reported a position in Exelixis in Q1 2023 and has held it in 3 quarters since.
  • 397 funds tracked by Wall St. Rank held Exelixis as of Q3 2023.

Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.